我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> MedImmune Ventures

商品編號: 9-814-023
出版日期: 2013/08/19
作者姓名:
Hamermesh, Richard G.;Lane, David
商品類別: Entrepreneurship
商品規格: 15p

再版日期: 2013/10/05
地域: Europe
產業: Health care services;Biotechnology;Finance & insurance;Pharmaceuticals
個案年度: 2011 -  2011

 


商品敘述:

Ron Laufer is the new Senior Managing Director of MedImmune Ventures'', the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer will make will reflect his vision for MedImmune Ventures and more broadly the incentives he faces as a corporate venture capitalist.


涵蓋領域:

Venture capital


相關資料:

Case Teaching Plan, (9-814-039), 8p, by Richard G. Hamermesh, Andrew Otazo